Leaders in Pharmaceutical Business Intelligence

Leaders in Pharmaceutical Business Intelligence Would Like to Announce Their Fourth Volume of Their BioMedical E-Book Series A: E-Books on Cardiovascular Diseases

Leaders in Pharmaceutical Business Intelligence announces Amazon ebook for Kindle Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine


Newtown, MA -- (SBWIRE) -- 01/15/2016 -- Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine which is now available on Amazon Kindle at http://www.amazon.com/dp/B019UM909A.

This e-Book is a comprehensive review of recent Original Research on Cardiovascular Diseases: Causes, Risks and Management and related opportunities for Targeted Therapy written by Experts, Authors and Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012.

Part 1 is concerned with Posttranslational Modification of Proteins, vital for understanding cellular regulation and dysregulation. Part 2 is concerned with Translational Medical Therapeutics, the efficacy of medical and surgical decisions based on bringing the knowledge gained from the laboratory, and from clinical trials into the realm of best practice. The time for this to occur in practice in the past has been through roughly a generation of physicians. That was in part related to the busy workload of physicians, and inability to easily access specialty literature as the volume and complexity increased. This had an effect of making access of a family to a primary care provider through a lifetime less likely than the period post WWII into the 1980s.

We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at: http://pharmaceuticalintelligence.com/biomed-e-books/

About Leaders in Pharmaceutical Business Intelligence
Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

- Delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

- Providing a social platform for scientists and clinicians to enter into discussion using social media

- Compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.